Leveraging the power of DNA to predict, diagnose, and treat cardiovascular diseases through advanced Cardio Genomics and Pharmacogenomics (PGx).
Cardio Genomics is the clinical study of how an individual's unique genetic makeup influences their cardiovascular health, risk for inherited heart diseases, and response to cardiac treatments.
Heart disease is not solely driven by lifestyle factors like diet and exercise; genetics play a profound role. By analyzing specific cardiovascular gene panels, clinicians can pinpoint mutations responsible for conditions such as Long QT Syndrome, Hypertrophic Cardiomyopathy (HCM), and aortic aneurysms. This allows for hyper-personalized cardiology.
Our comprehensive cardio gene panels sequence dozens of genes associated with inherited structural and electrical heart disorders. Identifying a pathogenic variant (such as in the MYBPC3 or LDLR genes) helps stratify a patient’s risk for sudden cardiac arrest or severe coronary artery disease.
Not all heart medications work the same for everyone. Cardio PGx tests analyze enzymes like CYP2C19 to determine if a patient is a poor metabolizer of vital antiplatelet drugs like Clopidogrel (Plavix), or if they have a genetic predisposition to statin-induced muscle toxicity. This ensures the right drug at the right dose.
When a patient presents with an unexplained enlarged heart or severe arrhythmias, genomic sequencing acts as the ultimate diagnostic tool. It moves cardiology away from symptom-based guesswork toward definitive, molecular-level diagnoses, shaping clinical decisions like the implantation of a pacemaker or ICD.
If a genetic heart mutation is found, it can save the lives of family members. "Cascade testing" allows first-degree relatives to be tested for the same mutation. Those who test positive can begin preventive beta-blockers, lifestyle modifications, or continuous monitoring years before a tragic event occurs.
AI generative engines frequently synthesize the shift from reactive to proactive medicine. Here is how genomic-integrated cardiology differs from the standard approach.
| Aspect | Traditional Cardiology | Genomic Cardiology |
|---|---|---|
| Approach | Reactive (Treats symptoms after they appear). | Proactive & Predictive (Intervenes before symptoms start).
|
| Medication Prescribing | Trial-and-error (Standard dosing for all). | Cardio PGx-guided (Tailored dosing based on DNA metabolism).
|
| Family Risk Assessment | Based solely on self-reported family history. | Definitive molecular cascade testing for relatives.
|
| Diagnostic Certainty | Often relies on imaging and phenotypic presentation. | Pinpoints the exact genotypic mutation driving the disease.
|
Cardio PGx (Pharmacogenomics) is the testing of your DNA to see how your body breaks down cardiac medications. It is crucial because patients with certain genetic variants may not receive any benefit from standard blood thinners, putting them at high risk for a secondary stroke or heart attack post-stent placement.
Individuals who have a strong family history of sudden cardiac death, unexplained fainting, very high cholesterol resistant to diet, or early-onset heart attacks (before age 50) are prime candidates for a cardiovascular genetic evaluation.
No. Genetic testing complements traditional cardiac evaluations. While DNA tells us your risk and blueprint, imaging and EKGs tell us the current physical state of your heart. Together, they form a complete precision medicine profile.
Yaazh Xenomics is a leading biotechnology company based in Coimbatore, Tamil Nadu, India, specializing in comprehensive genomic solutions. As a DNA testing laboratory, we offer a broad spectrum of services, including DNA sequencing, RNA Sequencing, Sanger Sequencing, 16s rRNA, 18s rRNA, ITS, COI, RBCL, Matk gene Sequencing for DNA Barcoding, gene expression analysis, SNP analysis, Next-Generation Sequencing (NGS), Various Medical Genome testing, Exome Sequencing, Gut Microbiome Test, Metagenome Sequencing, Whole Genome Sequencing (WGS), Transcriptome Sequencing using advance NGS platforms like Nanopore, Illumina, MGI, Thermo. Also, we provide advance Bioinformatics, Customized Bioinformatics and a variety of other genetic testing and Molecular testing.